bmy 7378 has been researched along with doxazosin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
Chalmers, DH; Kenny, BA; Naylor, AM; Philpott, PC | 1 |
Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
Amantini, C; Carrieri, A; Del Bello, F; Farande, Y; Giannella, M; Leonardi, A; Lucciarini, R; Piergentili, A; Pigini, M; Poggesi, E; Quaglia, W; Rafaiani, G; Santoni, G | 1 |
Amantini, C; Bonifazi, A; Del Bello, F; Farande, Y; Farfariello, V; Giannella, M; Leonardi, A; Menegon, S; Nabissi, M; Piergentili, A; Pigini, M; Poggesi, E; Quaglia, W; Santoni, G | 1 |
1 review(s) available for bmy 7378 and doxazosin
Article | Year |
---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
4 other study(ies) available for bmy 7378 and doxazosin
Article | Year |
---|---|
Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Aorta; Binding, Competitive; Dose-Response Relationship, Drug; Doxazosin; Male; Norepinephrine; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Vasodilation | 1995 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
Topics: Adrenergic alpha-1 Receptor Antagonists; Benzene; Cell Line, Tumor; Cell Survival; Dioxanes; Ethylamines; Humans; Models, Molecular; Molecular Structure; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-1; Serotonin Receptor Agonists; Structure-Activity Relationship | 2008 |
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
Topics: Binding Sites; Cell Line; Dioxanes; Humans; Magnetic Resonance Spectroscopy; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-1; Receptors, Serotonin, 5-HT1; Stereoisomerism; Structure-Activity Relationship | 2013 |